ANTI-INHIBITOR COAGULANT COMPLEX for Off label use: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 27 adverse event reports in the FDA FAERS database where ANTI-INHIBITOR COAGULANT COMPLEX was used for Off label use.
Most Reported Side Effects for ANTI-INHIBITOR COAGULANT COMPLEX
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Haemorrhage | 380 | 26.4% | 19 | 55 |
| Treatment failure | 135 | 9.4% | 0 | 1 |
| Drug ineffective | 129 | 9.0% | 14 | 26 |
| Therapy partial responder | 104 | 7.2% | 72 | 21 |
| Haemarthrosis | 92 | 6.4% | 3 | 31 |
| Acquired haemophilia | 77 | 5.4% | 75 | 24 |
| Pre-existing disease | 74 | 5.2% | 74 | 22 |
| Death | 59 | 4.1% | 59 | 4 |
| Factor viii inhibition | 56 | 3.9% | 3 | 21 |
| Anti factor viii antibody positive | 49 | 3.4% | 2 | 6 |
| Joint swelling | 45 | 3.1% | 0 | 21 |
| Arthralgia | 44 | 3.1% | 0 | 15 |
| Haematoma | 40 | 2.8% | 2 | 18 |
| Fall | 38 | 2.6% | 3 | 20 |
| Muscle haemorrhage | 36 | 2.5% | 2 | 17 |
Other Indications for ANTI-INHIBITOR COAGULANT COMPLEX
Haemophilia (335)
Factor viii deficiency (317)
Acquired haemophilia (215)
Product used for unknown indication (213)
Prophylaxis (122)
Haemorrhage (116)
Haemorrhage prophylaxis (56)
Post procedural haemorrhage (48)
Haemophilia a with anti factor viii (44)
Haemostasis (32)
Other Drugs Used for Off label use
LENALIDOMIDE (5,767)
ECULIZUMAB (3,550)
CERTOLIZUMAB PEGOL (2,256)
ABOBOTULINUMTOXINA (2,170)
LEVETIRACETAM (2,161)
APREMILAST (1,995)
PROPRANOLOL (1,576)
CETIRIZINE (1,416)
HUMAN IMMUNOGLOBULIN G (1,129)
THALIDOMIDE (1,033)